Background-In persons with coronary artery disease (CAD), low body mass index is associated with greater mortality, however it is uncertain if low muscle mass is a risk factor for mortality in this setting.
INTRODUCTION
While obesity is a risk factor for incident coronary artery disease (CAD), its significance in individuals with established CAD has recently been questioned. In a meta-analysis that included 40 studies and over 250,000 individuals with CAD, there was a reverse J-shaped relationship between body mass index (BMI) and mortality; individuals with the BMI < 20.0 had the greatest mortality risk, while individuals with obesity (BMI 30.0-34.9) or severe obesity (BMI > 35) were not at greater risk than normal weight individuals (BMI 20.0-24.9). 1 Because BMI does not discriminate between its relative contributions from adiposity or muscle, this finding has led many to hypothesize that the high death risk associated with low BMI may be due to deficiency in muscle rather than adiposity. [2] [3] [4] Implicit is the hypothesis that low muscle mass may be a risk factor for mortality in persons with established CAD. Yet, to our knowledge, this association has not been studied in the setting of prevalent CAD.
It is estimated that > 98% of creatinine comes from muscle, 5 where it is produced and secreted into serum at a continuous rate. 6 Once in serum, creatinine is almost exclusively excreted in the urine in individuals without severe kidney failure. 7, 8 Because muscle mass does not change rapidly within individuals, elevations in serum creatinine typically reflect decrements in glomerular filtration rate. When the serum creatinine concentration is in steady state, however, regardless of its serum concentration, creatinine generation must equal creatinine excretion. Thus, the urinary creatinine excretion rate has been recognized as a marker of muscle mass for nearly a century. 9 Here, we evaluate the association of CER with all-cause mortality among a cohort of out-patients with stable CAD. Based on the relationship of low BMI with mortality reported elsewhere, we hypothesized that lower CER would be associated with mortality independent of traditional CAD risk factors and kidney function.
METHODS

Study Participants
The Heart and Soul Study is an observational study designed to investigate the influence of psychosocial factors on progression of CAD. Methods have been described previously. 10 Briefly, participants were recruited from out-patient clinics in the San Francisco Bay Area if they met one of the following inclusion criteria: (i) history of myocardial infarction; (ii) angiographic evidence of >50% stenosis in one or more coronary vessels; (iii) evidence of exercise-induced ischemia by treadmill or nuclear testing; (iv) history of coronary revascularization or (v) documented diagnosis of coronary artery disease by an internist or cardiologist. Participants were excluded if they were not able to walk one block, had a myocardial infarction within the past 6 months or were likely to move out of the area within three years. The study protocol was approved by the Institutional Review Boards of participating institutions, and all participants provided written informed consent.
Between September 2000 and December 2002, 1,024 participants enrolled and underwent a daylong baseline study appointment that included a medical history, physical examination, and a comprehensive health status questionnaire. Out-patient 24-hour timed urine collections, and fasting (12 h) morning venous blood samples were obtained. For the present analysis, we excluded 107 participants with missing timed urine collections, and 20 individuals without complete covariate data, providing a final analytic sample of 903 participants. Participants were followed for death through December 1, 2008 . By this date, 38 (3.7%) participants had been lost to follow-up.
Measurements
Urinary Creatinine Excretion Rate-The protocol used for timed urine collection has been described previously. 11 In brief, participants received detailed instructions regarding accurate urine collection and specimen refrigeration. Subjects were asked to void at the end of their study appointment, and to begin the collection from that point forward. Research personnel arrived at the patient's home 24-hours after the timed collection was initiated, to avoid over-or under-collection. If participants reported missing any urine, or collections were < one liter or > three liters, collections were repeated. When participants were unable to collect all urine for any reason, no data were recorded. Urine volume was recorded (ml), and creatinine was measured by the rate Jaffe method. CER was calculated in mg/day (urine volume [ml] * urine creatinine [mg/dL]/100).
Mortality-Between the baseline examination and December 1, 2008, annual telephone interviews were conducted with study participants (or their proxy) for vital status. For any reported event, medical records, death certificates, and coroner's reports were retrieved. Date of death was recorded to provide time-to-event data from the baseline examination.
Other Participant Characteristics and Laboratory Tests-Age, sex, and race/ ethnicity were determined by questionnaire. Weight and height were measured in light clothes and without shoes. Body mass index (BMI) was calculated (wt [kg]/height [meters] 2 ). Waist and hip circumferences were measured with a flexible plastic measure to the nearest 0.1 centimeter. Waist circumference was measured midway between the lower rib margin and iliac crest. Hip circumference was measured at the level of the greater trochanters. Waist to hip ratio (WHR) was calculated. Serum cystatin-C concentrations were measured with a particleenhanced immunonephelometric assay 12 (N Latex Cystatin-C, Dade Behring, Inc.) and used to calculate estimated glomerular filtration rate (eGFR cys ) using the formula eGFR cys = 76.7 * cystatin C −1.19 . This formula has been validated with comparison to iothalamate measured GFR in a pooled cohort of kidney disease studies; showed little bias, and provided a noncreatinine based method to adjust for kidney function for this study. 13 History of smoking, hypertension, and diabetes were determined by questionnaire. Systolic and diastolic blood pressures were measured after five minutes rest in the supine position. Total cholesterol, and high-density lipoprotein (HDL) cholesterol were measured using standard clinical chemistry analyzers. High sensitivity C-reactive protein (hsCRP) was measured with the Roche (Indianapolis, Indiana) and the Beckman Extended Range (Galway, Ireland) assays. 14 Fasting glucose was measured by a standard clinical analyzer, and fasting insulin was measured by ELISA (Linco Research, St. Charles, MO). Participants provided rest transthorasic echocardiograms that were read by one expert cardiologist who was blinded to all clinical data, as described previously. 15 Left ventricular (LV) mass was calculated using the truncated ellipsoid method, 16 and was indexed to body surface area. LV ejection fraction was determined by biplane method of disks. 17 Thereafter, subjects underwent exercise treadmill test by the modified Bruce protocol. Max number of metabolic equivalents (METs) and maximum heart rate achieved were recorded.
Statistical Analysis
Exploratory analyses demonstrated that the distribution of CER was approximately Gaussian, but differed substantially in men and women. Thus, for Kaplan Meier survival estimates and Cox models, we evaluated sex-specific tertiles of CER as the primary predictor variable. In companion analyses, we evaluated CER as a continuous predictor, defined as one standard deviation lower level in the unadjusted distribution of CER in our dataset. Other secondary predictor variables that were measured on a continuous scale were also evaluated per standard deviation lower level to facilitate comparisons of their strengths of associations with mortality.
We used linear regression to evaluate age and sex adjusted association of key body composition variables, kidney function, and inflammatory markers with CER. Next, we explored the age and sex adjusted functional form of body composition measurements with CER using generalized additive models to fit a cubic B-spline function. The extreme five percent of CER measurements were excluded to avoid implausible extrapolations of the functional form from the extremes of the data distribution. Next, Kaplan Meier survival curves were developed to explore the unadjusted association of CER tertiles with mortality. Subsequently, Cox proportional hazards models were used to evaluate this association while adjusting for potential confounders. Sequential models were developed: model one was unadjusted; model two adjusted for age and sex; and model three adjusted for model two variables plus BMI. Sensitivity analyses were conducted to determine whether results were similar if weight, waist circumference, hip circumference, or WHR replaced BMI in model three. A final model adjusted for the model three variables plus African-American race, eGFR, natural log of Creactive protein and traditional CAD risk factors (diabetes, hypertension, smoking, systolic blood pressure, diastolic blood pressure, total and HDL cholesterol). The functional forms of each continuous variable with mortality were investigated, and when non-linear associations were observed, appropriate categorizations were employed to capture the observed functional form. Last, we explored the functional form of CER with mortality in the fully adjusted model using a cubic B-spline function. To investigate whether low CER identifies individuals with occult systemic illness which may have led to higher short-term mortality risk, we evaluated a time interaction term, dichotomized at three years after baseline. Last, multiplicative interaction terms were created to evaluate whether results were modified by sex, and analyses were stratified by sex. Results were similar, so only models combining both sexes are presented to maximize statistical power.
To determine whether any association between CER and mortality may be due to incomplete urine collections in patients with low CER, we performed a sensitivity analysis excluding participants whose measured 24 hour urinary creatinine clearance was more than 30% different than their eGFR cys .. This takes advantage of the fact that CER divided by serum creatinine equals creatinine clearance (in ml/min); an estimate of GFR. 18 eGFR cys provided another estimate of GFR, yet is independent of the quality of the timed urine collection and of creatinine kinetics. Creatinine clearance was normalized to body surface area (BSA) because eGFR cys is calculated as an estimate of GFR normalized to BSA, to facilitate comparison of the two GFR estimates.
Proportional hazards assumptions were assessed by visually inspecting log-minus-log plots and plots of Schoenfeld residuals vs. survival time. No evidence of violations was observed. Analyses were performed using STATA Statistical Software, version 9.2 (College Station, TX). P values < 0.05 were considered statistically significant for all comparisons including multiplicative interaction terms.
RESULTS
Baseline characteristics of the study participants are shown in Table 1 . The mean age of the 903 participants was 67 ± 11 years, 32% were obese, and 31% had moderate CKD determined by cystatin C. The mean CER was 1197 ± 412 mg/day. Table 2 shows the age and sex adjusted associations of demographics, body composition, kidney function, physical fitness variables, and LV mass and LV ejection fraction with CER. As expected, younger participants and men had higher CER, and greater body mass by each measurement was associated with greater CER. When assessed by the relative difference in CER, the association was strongest for weight followed by BMI, whereas WHR had the weakest association with CER. Age and sex adjusted spline functions demonstrated that these associations were fairly linear across the distribution of body composition measures (Figure 1 ). Individuals achieving greater METs and maximum heart rate on the Bruce treadmill test had greater CER. Individuals with greater CER also had greater LV ejection fraction on average, although the association did not reach statistical significance. Lower eGFR cys was also associated with lower CER, but this association was modest in strength. African American race, C-reactive protein levels, and LV mass were not significantly associated with CER.
Association of Creatinine Excretion Rate with Mortality
Participants were followed for a median of 6.0 years (interquartile range 4.6 to 6.1 years), during which 232 participants (26%) died. Figure 2 shows Kaplan Meier survival estimates by sex-specific CER tertiles. In the highest CER tertile, 37 (12%) deaths occurred compared with 69 (23%) among persons in the middle tertile, and 126 (42%) among persons in the lowest tertile. Accordingly, compared to the highest CER tertile, subjects in the lowest tertile were at approximately four fold risk of death in unadjusted analysis (Table 3 ). This association was attenuated to approximately three fold when adjusted for age and sex (mean age ± SD was 61 ± 10, 67 ± 10, and 71 ± 11 and for highest, middle, and lowest tertiles, respectively). Adjustment for BMI was complex, as the association of BMI with mortality was not linear. In age and sex adjusted models, subjects in the lowest BMI quintile (< 24.1 kg/m 2 ) were at 1.5 fold greater risk for mortality (P=0.03) compared to subjects in the second quintile, and mortality risk was similar across quintiles two to five (Figure 3) . Therefore, we categorized BMI by the lowest quartile vs. quartiles two to five. With this adjustment, the lowest CER tertile remained associated with approximately a threefold mortality risk (Table 3) . Results were similar when each quintile of BMI was modeled as separate indicator variables, when BMI was modeled continuously, and when BMI plus a quadratic term (BMI 2 ) were modeled concurrently. Results were also similar when weight, height, waist circumference, hip circumference, or WHR replaced BMI (data not shown). When the model was further adjusted for traditional CAD risk factors, kidney function, and CRP, the association was modestly further attenuated, but the lowest CER tertile remained at two fold greater risk of mortality compared to the highest tertile. The functional form of the relationship of CER with mortality was linear throughout the distribution of CER values in the final multivariable model (Figure 4 ). Results were similar when men and women were evaluated separately (interaction P-value 0.21). Table 4 shows hazard ratios for mortality for each predictor variable in the final model. When comparing continuous predictor variables per standard deviation change, only age (per SD, 11 years) was clearly more strongly associated with mortality than CER. The associations of CER, eGFR, and CRP with mortality were of similar strength. Associations of the remainder of the continuously predictors were more modest or altogether absent. Compared to the binary risk factors, one standard deviation lower CER was weaker than male sex and current smoking, similar in strength to diabetes, and stronger than the lowest quintile of BMI, hypertension or African-American race. Table 5 shows the result of further adjustment of the multivariable model for variables that might mediate the association of CER with mortality. Additional adjustment for maximum heart rate and METs achieved on the Bruce exercise treadmill had little effect on the association of CER with mortality. Results were also similar with adjustment for LV mass index and ejection fraction, prior CVD history, or fasting blood glucose and insulin levels. To evaluate whether low CER may be a marker of occult illness and might therefore be more strongly associated with short-term mortality, we evaluated whether the association differed in individuals who died ≤ 3 vs. > 3 years after their baseline visit. Results were similar. In this model, each standard deviation lower CER was associated with a hazard ratio of 1.39 (95% CI 1.03-1.85) in participants who died in ≤ 3 years (n=80), and 1.35 (95% CI 1.09-1.69) in those who died after 3 years (interaction P-value 0.91).
Evaluation of Potential Mechanisms
Sensitivity Analyses
To investigate potential misclassification bias introduced by under-or over-collected urine specimens, we excluded participants whose measured urinary creatinine clearance was discrepant with eGFR cys by > 30% (N=267, 30%). Among those excluded, CrCl overestimated eGFR cys in 136, and underestimated eGFR cys in 131 individuals. The association of CER with mortality was similar in the remaining 636 participants compared to the entire sample. Participants with CER in the lowest tertile were at 3 fold mortality risk compared to the highest tertile (HR 2.99; 95% CI 1.59-5.62), and one standard deviation lower CER was associated with 40% greater mortality risk (HR 1.40; 95% CI 1.03to 1.90) in the fully adjusted model.
DISCUSSION
We demonstrate that lower CER is strongly associated with mortality in out-patients with stable CAD. The association showed a dose-response relationship, and was independent of body mass index, waist hip ratio, kidney function, inflammatory biomarkers, or traditional CAD risk factors. Adjustment for markers of physical fitness, LV structure and function, and insulin resistance rendered the association effectively unaltered. The association was approximately equal in strength to that of kidney function and CRP, which are two of the strongest risk factors for mortality in the secondary prevention setting. 19 These findings have important implications for individuals with prevalent CAD.
First, while it is frequently hypothesized that decreased muscle mass is associated with mortality in persons with CAD, 1, 20 to our knowledge this hypothesis has not previously been evaluated. Because creatinine is a by-product of muscle, and excreted almost exclusively in the urine, CER is a surrogate for muscle mass, irrespective of serum creatinine concentrations. 9 For example, in a sample of 664 community-living individuals (mean urinary creatinine clearance 105 ± 32 ml/min) in Minnesota, depending on log-transformation and correction for body surface area, between 37 and 62% of the variance in CER was accounted for by muscle mass determined by dual energy x-ray absorptiometry (A. Rule, personal communication). 21 In another study among 25 young healthy volunteers, mid-arm muscle area by computed tomography accounted for 88% of the variance in CER (r=0.94, R 2 =0.88). 22 In patients with end-stage renal disease, muscle mass measured by bioelectrical impedance accounted for 85% of the variances in total (residual renal plus dialysis) creatinine clearance (r=0.92, r 2 =0.85). 23 Thus, the most likely explanation for the data presented here is that low muscle mass is a strong risk factor for mortality in persons with established CAD.
The mechanisms responsible for this association, however, remain uncertain. Oterdoom and colleagues recently conducted a study evaluating the association of CER with mortality among community-living Europeans predominantly without CVD and demonstrated that low CER was strongly associated with mortality, similar to data presented here. 24 Because skeletal muscle is the main site for insulin mediate glucose disposal, these investigators hypothesized that low CER may be associated with insulin resistance. In their study, adjustment for fasting glucose and insulin had little effect on the association of CER with mortality; results that we confirm here, and can extend to populations with CAD. In their discussion, Oterdoom et. al. suggest that CER may be a marker of physical inactivity and/or protein calorie malnutrition, yet they lacked measurement of these factors and suggested that these hypotheses be studied elsewhere. Here, we observed that individuals with lower CER achieved lower maximum METs and lower maximum heart rate on the Bruce protocol, however accounting for these measurements had virtually no effect on the association of CER with mortality. Moreover, adjustment for LV mass and ejection fraction had little effect. Therefore, while the mechanisms responsible for the association of CER with mortality remain unknown, our data suggest that low CER is more than a marker of physical fitness or of cardiovascular structure or function, and might therefore provide complimentary risk information above and beyond traditional markers of disease severity among persons with CAD.
It remains possible that factors other than muscle mass may also influence CER, although their contributions are thought to be smaller. 6, 25, 26 Among these, dietary consumption of meat (particularly undercooked meat) may be the most important. We lack diet data, and thus future studies are required to determine the relative contributions of muscle mass vs. diet to CER and mortality in the secondary prevention setting. Infections, fever, trauma, and exercise may also modestly increase CER. [27] [28] [29] [30] [31] Because each is associated with greater CER, and would more likely also be associated with greater rather than lesser mortality risk, these factors are unlikely to explain the inverse association CER with mortality demonstrated here. These observations suggest, however, that CER may be influenced not only by muscle mass, but may also reflect muscle health and function. Thus, future studies should evaluate the relative contributions of muscle quantity and quality to CER, as well as the independent associations of muscle quantity and quality to health outcomes.
It is common to statistically adjust for BMI as surrogates for body composition in studies evaluating risk factors for CAD. Here, low CER and BMI were each independently associated with mortality. Similarly, adjustment for body weight, height, or waist to hip ratio did not meaningfully attenuate the association of CER with mortality. These data suggest that adjustment for standard measures of body composition will not account for possible confounding by differences in muscle mass. If our findings are confirmed, future studies should consider measuring and adjusting for CER or other measures of muscle mass when evaluating risk factors for CAD and its consequences. Beyond minimizing confounding, such studies may also identify new pathways influencing prognosis in CAD.
This study is the first to our knowledge to evaluate the health consequences of CER in persons with CAD. CER has important advantages and disadvantages in this setting. First, our CER measurements were collected in a research setting with strict quality control. Timed urine collections in clinical practice are frequently over-or under-collected. 18 At the outset, it was possible that participants with a greater burden of comorbidity might have differentially undercollected their urine, and that this feature may have biased our results. We took advantage of the fact that dividing CER by serum creatinine concentration calculates creatinine clearance (an estimate of GFR). 18 In a sensitivity analysis, we excluded persons whose creatinine clearance differed more than 30% from GFR calculated from a cystatin C-based equation, which is independent of creatinine kinetics and of the accuracy of the timed urine collections. In this analysis, we found that the association of CER with mortality was similar to that observed in the entire cohort. These data provide reassurance that inaccurate timed collections were unlikely to have led to our results. Our study has additional limitations. While prior studies have demonstrated that CER is correlated with muscle mass, we lacked other measures of muscle mass to determine their relative strength with mortality compared to CER. Our study participants were mostly older men, and all had prevalent CVD. Results may differ in other populations.
CER also has important advantages over other measures of muscle mass. Timed urine collection and creatinine measurement is inexpensive, and can be readily obtained even in resource poor healthcare settings, where DXA scans or other measures of muscle mass may not be routinely available or feasible. With the growing burden of CAD world-wide, 32 if our findings are confirmed, CER may provide a cost-effective and readily available mechanism to identify individuals at particularly high risk for death in the secondary prevention setting. Moreover, the American Heart Association has recommended prescription of resistive exercise interventions for individuals with established CAD. 20, 33 It is possible that CER measurement might ultimately be useful to identify individuals who might benefit most from resistive exercise interventions, and/or to monitor the response to such interventions.
In summary, low CER is strongly associated with mortality in out-patients with prevalent CAD. Adjustment for conventional measures of body composition did not materially attenuate this association. If confirmed, CER may represent a novel, potentially modifiable, readily available, and inexpensively measured risk factor for mortality in the secondary prevention setting.
CLINICAL PERSPECTIVE
Recent studies have demonstrated that low BMI is associated with mortality in individuals with CAD, while higher BMI is not. Lower BMI may reflect low muscle mass rather than low fat. When serum creatinine is in steady state, urinary creatinine excretion rate (CER) is proportional to muscle mass. In 903 out-patients with stable CAD, we collected 24-hour urine collections and evaluated the relation of CER with mortality over 6 years. Individuals within the lowest tertile of CER were at > 2-fold mortality risk compared to the highest tertile, independent of BMI, waist-hip ratio, traditional CAD risk factors, inflammatory biomarkers, and kidney function. Timed urine collection may provide an inexpensive and readily available method to measure muscle mass in out-patients with CAD and to garner additional information on mortality risk, independent of conventional measures of body composition or traditional CAD risk factors. Future studies are required to determine if resistive exercise and/or nutritional interventions can improve CER and whether such improvements in CER are associated with demonstrable improvements in health outcomes. Age and sex adjusted spline functions demonstrating the cross-sectional association of body mass index (A) and waist hip ratio (B) with creatinine excretion rate in persons with coronary artery disease. Solid line represents the hazard ratio, and dotted lines represent the 95% confidence intervals. The extreme 5% of the data distribution was excluded to avoid implausible extrapolation from the extremes of the data. Natural piecewise cubic spline function demonstrating that the adjusted association of creatinine excretion rate with mortality was fairly linear in persons with coronary artery disease. Solid line represents the hazard ratio, and dotted lines represent the 95% confidence intervals. The extreme 5% of the data distribution was excluded to avoid implausible extrapolation from the extremes of the data. *The spline function was adjusted for age, sex, race, BMI (lowest quintile vs. greater), diabetes, hypertension, current smoking, systolic blood pressure, diastolic blood pressure, total cholesterol, HDL cholesterol, eGFR, and Ln(CRP). Circulation. Author manuscript; available in PMC 2011 March 23.
